Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.

Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays Revision: v3.4.2 and removes the earlier government-funding notices and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedThe page now shows a glossary toggle, and updates to labels such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision note to v3.4.0, which are formatting and metadata changes rather than changes to the study details themselves. There are no changes to core study content, eligibility, endpoints, or primary conclusions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive study details appear to be affected.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations were updated with new sites across multiple U.S. states and international regions (Australia, United Kingdom, Canada), and several previously listed locations were removed. This update changes the geographic footprint of the trial.SummaryDifference2%

- Check92 days agoChange DetectedThe update appears to be a site-wide revision tag with no changes to the study content or displayed details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.